Home > News > Common Nanoparticle Shown to Be Non-toxic to Blood Cells
October 5th, 2005
Common Nanoparticle Shown to Be Non-toxic to Blood Cells
Abstract:
Though many kinds of nanoparticles, loaded with a variety of drugs and imaging agents, are making their way toward the clinic, questions about nanoparticle toxicity remain to be answered. Given that the majority of nanoparticles are intended to travel to tumors through the bloodstream, the effects of nanoparticles on blood cells are of particular concern to those developing nanoparticle-based therapeutic and imaging agents. Now, a series of experiments by researchers at the University of Kentucky have found no ill effects when blood cells are exposed to one common type of nanoparticle.
Source:
nano.cancer.gov
Bookmark:
| Related Links |
| Related News Press |
Nanomedicine
New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025
New imaging approach transforms study of bacterial biofilms August 8th, 2025
Cambridge chemists discover simple way to build bigger molecules – one carbon at a time June 6th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Materials/Metamaterials/Magnetoresistance
First real-time observation of two-dimensional melting process: Researchers at Mainz University unveil new insights into magnetic vortex structures August 8th, 2025
Researchers unveil a groundbreaking clay-based solution to capture carbon dioxide and combat climate change June 6th, 2025
A 1960s idea inspires NBI researchers to study hitherto inaccessible quantum states June 6th, 2025
Institute for Nanoscience hosts annual proposal planning meeting May 16th, 2025
Announcements
Decoding hydrogen‑bond network of electrolyte for cryogenic durable aqueous zinc‑ion batteries January 30th, 2026
COF scaffold membrane with gate‑lane nanostructure for efficient Li+/Mg2+ separation January 30th, 2026
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||